Deberdt相关文献与解析，生知库 | 链接生命科学的每一步

Vander Elst, Zoë; Laenen, Annouschka; Deberdt, Jana; Delemarre, Lotte; Vermeersch, Pieter; Frans, Glynis; Naulaers, Gunnar; Gijsen, Matthias; Dreesen, Erwin; Spriet, Isabel; Allegaert, Karel; Smits, Anne

Human

发表日期：2026

文献求助收藏

Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications

更正：巴瑞替尼在风湿病和皮肤病适应症中对高危人群特殊关注事件的安全性：基于随机试验数据的分析

期刊:Advances in Therapy

影响因子:4

doi:10.1007/s12325-025-03244-1

Taylor, Peter C; Bieber, Thomas; Alten, Rieke; Witte, Torsten; Galloway, James; Deberdt, Walter; Issa, Maher; Haladyj, Ewa; De La Torre, Inmaculada; Grond, Susanne; Wollenberg, Andreas

发表日期：2025

文献求助收藏

Evolution in peak oxygen uptake and its impact on physical activities of daily living in chronic kidney disease and transplantation

慢性肾病和肾移植患者峰值摄氧量的变化及其对日常生活体力活动的影响

期刊:BMJ Open Sport & Exercise Medicine

影响因子:3.2

doi:10.1136/bmjsem-2025-002481

Vandecruys, Marieke; Schockaert, Gillian; Coemans, Maarten; Denhaerynck, Kris; Deberdt, Géraldine; Cornelissen, Véronique; Van Craenenbroeck, Amaryllis H; De Smet, Stefan

发表日期：2025

文献求助收藏

Letter to the Editor Regarding "Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases"

致编辑的信，主题为“评估接受巴瑞替尼治疗的类风湿关节炎患者与接受TNF抑制剂治疗的患者相比发生VTE、MACE和严重感染的风险：一项利用疾病登记和索赔数据库对常规护理患者进行的多数据库研究”

期刊:Rheumatology and Therapy

影响因子:2.9

doi:10.1007/s40744-025-00796-0

Salinas, Claudia A; Louder, Anthony; Polinski, Jennifer; Zhang, Tancy C; Bower, Hannah; Phillips, Syd; Song, Yufei; Rashidi, Emaan; Bosan, Rafia; Chang, Hsiu-Ching; Foster, Nicole; Gershenson, Bernice; Yamanaka, Hisashi; Kishimoto, Mitsumasa; Tanaka, Yoshiya; Fischer, Peter; Zhu, Baojin; Faries, Douglas; Mai, Xiaodan; Doherty, Brett T; Grelaud, Angela; Thurin, Nicolas H; Askling, Johan; Deberdt, Walter

Using causal effect estimation to evaluate occupational stress factors during a weekend on-call shift among general practitioners in training

运用因果效应估计法评估全科医生培训生周末值班期间的职业压力因素

期刊:BMC Primary Care

影响因子:2.6

doi:10.1186/s12875-025-03140-1

Deberdt, Géraldine; Rabaey, Paloma; Van Damme, Sam; Quenon, Laure-Ann; Decat, Peter; Demeester, Thomas

发表日期：2025

文献求助收藏

Assessing the Burden of Respiratory Syncytial Virus-related Bronchiolitis in Primary Care and at 15-Day and 6-Month Follow-up Before Prophylaxis in France: A Test-negative Study

一项在法国开展的、针对基层医疗机构中呼吸道合胞病毒相关细支气管炎的负担评估研究，该研究在预防性治疗前分别进行了15天和6个月的随访。

期刊:Pediatric Infectious Disease Journal

影响因子:2.2

doi:10.1097/INF.0000000000004360

Rybak, Alexis; Cohen, Robert; Bangert, Mathieu; Kramer, Rolf; Delobbe, Jean-François; Deberdt, Patrice; Cahn-Sellem, Fabienne; Béchet, Stéphane; Levy, Corinne

Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications

巴瑞替尼在风湿病和皮肤病适应症中对高危人群特殊关注事件的安全性分析：来自随机试验数据的分析

期刊:Advances in Therapy

影响因子:4

doi:10.1007/s12325-023-02445-w

Taylor, Peter C; Bieber, Thomas; Alten, Rieke; Witte, Torsten; Galloway, James; Deberdt, Walter; Issa, Maher; Haladyj, Ewa; De La Torre, Inmaculada; Grond, Susanne; Wollenberg, Andreas

发表日期：2023

文献求助收藏

Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19

更正：巴瑞替尼在风湿病、皮肤病和 COVID-19 临床试验中的安全性结果回顾

期刊:Advances in Therapy

影响因子:4

doi:10.1007/s12325-023-02526-w

Bieber, Thomas; Feist, Eugen; Irvine, Alan D; Harigai, Masayoshi; Haladyj, Ewa; Ball, Susan; Deberdt, Walter; Issa, Maher; Grond, Susanne; Taylor, Peter C

发表日期：2023

文献求助收藏

Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases

巴瑞替尼治疗类风湿关节炎患者与TNF抑制剂治疗类风湿关节炎患者的VTE、MACE和严重感染评估：一项利用疾病登记和索赔数据库对常规护理患者进行的多数据库研究

期刊:Rheumatology and Therapy

影响因子:2.9

doi:10.1007/s40744-022-00505-1

Respiratory Syncytial Virus in Outpatient Children with Bronchiolitis: Continuous Virus Circulation During the Nonepidemic Period

门诊毛细支气管炎患儿呼吸道合胞病毒感染：非流行期病毒持续循环

期刊:Pediatric Infectious Disease Journal

影响因子:2.2

doi:10.1097/INF.0000000000004105

Rybak, Alexis; Cohen, Robert; Kramer, Rolf; Béchet, Stéphane; Delobbe, Jean-François; Dagrenat, Véronique; Vié Le Sage, François; Deberdt, Patrice; Wollner, Alain; Bangert, Mathieu; Levy, Corinne

Human serum albumin: prediction model and reference values for preterm and term neonates

人血清白蛋白：早产儿和足月新生儿的预测模型和参考值

Correction to: Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications

更正：巴瑞替尼在风湿病和皮肤病适应症中对高危人群特殊关注事件的安全性：基于随机试验数据的分析

Evolution in peak oxygen uptake and its impact on physical activities of daily living in chronic kidney disease and transplantation

慢性肾病和肾移植患者峰值摄氧量的变化及其对日常生活体力活动的影响

Letter to the Editor Regarding "Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases"

致编辑的信，主题为“评估接受巴瑞替尼治疗的类风湿关节炎患者与接受TNF抑制剂治疗的患者相比发生VTE、MACE和严重感染的风险：一项利用疾病登记和索赔数据库对常规护理患者进行的多数据库研究”

Using causal effect estimation to evaluate occupational stress factors during a weekend on-call shift among general practitioners in training

运用因果效应估计法评估全科医生培训生周末值班期间的职业压力因素

Assessing the Burden of Respiratory Syncytial Virus-related Bronchiolitis in Primary Care and at 15-Day and 6-Month Follow-up Before Prophylaxis in France: A Test-negative Study

一项在法国开展的、针对基层医疗机构中呼吸道合胞病毒相关细支气管炎的负担评估研究，该研究在预防性治疗前分别进行了15天和6个月的随访。

Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications

巴瑞替尼在风湿病和皮肤病适应症中对高危人群特殊关注事件的安全性分析：来自随机试验数据的分析

Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19

更正：巴瑞替尼在风湿病、皮肤病和 COVID-19 临床试验中的安全性结果回顾

Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases

巴瑞替尼治疗类风湿关节炎患者与TNF抑制剂治疗类风湿关节炎患者的VTE、MACE和严重感染评估：一项利用疾病登记和索赔数据库对常规护理患者进行的多数据库研究

Respiratory Syncytial Virus in Outpatient Children with Bronchiolitis: Continuous Virus Circulation During the Nonepidemic Period

门诊毛细支气管炎患儿呼吸道合胞病毒感染：非流行期病毒持续循环